POWER TO RESTORE WITHOUT LEAVING A TRACE. The only remaining evidence of the trauma

Similar documents
STIMULAN POWER TO TRANSFORM OUTCOMES

STIMULAN POWER TO TRANSFORM OUTCOMES

Perfect partner for your infection management strategy

Calcium Phosphate Cement

The injectable, self-setting calcium phosphate bone graft substitute.

Bone Void Filler. Callos. The Next Generation in Calcium Phosphate Cement A COLSON ASSOCIATE

ADVANCED BONE GRAFT SYSTEM OVERVIEW

ctive Bone Bonding Bone Regeneration Osteostimulation*

Type of evidence. Design rationale. Economic analysis

Clinical. Solutions. Synthes Solutions. Foot and Ankle.

chronos Bone Void Filler. Beta-Tricalcium Phosphate ( β-tcp) bone graft substitute.

Patient Guide. Intramedullary Skeletal Kinetic Distractor For Tibial and Femoral Lengthening

Surgical Technique Guide. Impact & Inject Formulations

Innovative Range of Regenerative Solutions

KASM Knee Articulating Spacer Mold. Surgical Summary

B U I L D S T R O N G B O N E F A S T

Technique Guide. chronos Strip. Osteoconductive betatricalcium phosphate ( -TCP) composite.

Calcium Phosphate Bone Void Filler TECHNIQUE GUIDE

CELLPLEX TCP SYNTHETIC CANCELLOUS BONE

INnate. Surgical Technique Guide. Anatomic Fixation in Your Hands. The INnate Implant

DVR Crosslock Distal Radius Plating System. Product Brochure

.org. Tibia (Shinbone) Shaft Fractures. Anatomy. Types of Tibial Shaft Fractures

RapidSorb Resorbable Tacks. Resorbable Fixation System.

Hoffmann II Micro External Fixation System. Indications for the Hand

Integra TenoGlide Tendon Protector Sheet

Power to Transform Outcomes

Radiology Case Reports. Bone Graft Extruded From an Intramedullary Nail Tract in the Tibia. Penelope J. Galbraith, M.D., and Felix S. Chew, M.D.

BIOACTIVE SYNTHETIC GRAFT

Indications. Neuro Surgery. Plastic Surgery. ENT Surgery. Oral Maxillofacial Surgery

CRANIAL RECONSTRUCTION SOLUTIONS

Made to make a difference

OSSIS is an ISO accredited company.

Biomaterials Line. MIS Corporation. All Rights Reserved.

OSSIS is an ISO accredited company.

Fracture Classification

Callos Bone Void Filler

Talos -C (HA) and the PEEK-OPTIMA HA Enhanced Technology

botiss biomaterials bone & tissue regeneration collacone max Innovative composite matrix socket preservation form-fitting resorbable composite

botiss dental bone & tissue regeneration biomaterials collacone max Innovative composite matrix socket preservation form-fitting resorbable composite

OUTCOME OF MANAGEMENT OF CLOSED PROXIMAL TIBIA FRACTURES IN TERTIARY HOSPITAL OF SURAT Karan Mehta 1, Prashanth G 2, Shiblee Siddiqui 3

In Vivo Heat-stimulus Triggered Osteogenesis

7/23/2018 DESCRIBING THE FRACTURE. Pattern Open vs closed Location BASIC PRINCIPLES OF FRACTURE MANAGEMENT. Anjan R. Shah MD July 21, 2018.

Radiological and histological analysis of synthetic bone grafts in recurring giant cell tumour of bone: a retrospective study

Lawrence A. DiDomenico, DPM, FACFAS

Trauma fixation choices chart your fracture

Fractures of the Proximal Tibia (Shinbone)

PATIENTS DESERVE A BETTER IMPLANT SOLUTION

Choice of spacer material for HTO! P. Landreau, MD Chief of Surgery Aspetar, Orthopaedic and Sports Medicine Hospital Doha, Qatar

AttraX. Portfolio. Surface Drives Performance

Graftys. Cross-selling. Indications. Comparison. Basic Science. Graftys 415 rue Claude Nicolas Ledoux Aix en Provence Cedex 4

Please understand that the values set forth here estimated ranges of of value for New York pain and

CERAMENT BONE VOID FILLER

Orthopedic & Sports Medicine, Bay Care Clinic, 501 N. 10th Street, Manitowoc, WI Procedure. Subtalar arthrodesis

4/28/2010. Fractures. Normal Bone and Normal Ossification Bone Terms. Epiphysis Epiphyseal Plate (physis) Metaphysis

MEDICAL DEVICE PATIENT LABEL AUGMENT. Bone Graft

ANATOMIC LOCKED PLATING SYSTEM

A WIDE RANGE OF REGENERATIVE SOLUTIONS

Fractures of the tibia shaft treated with locked intramedullary nail Retrospective clinical and radiographic assesment

REASONS TO USE R.T.R.

Bioactive Bone Glass Substitute

Treatment of Distal Radius Bone Defects with Injectable Calcium Sulphate Cement

In Vivo Evaluation of BioSphere Bioactive Bone Graft Putty: Improved Bone Formation

3D printed. Patient Specific. titanium alloy truss implants

EXACTECH KNEE. Operative Technique ADDENDUM. Metaphyseal Cones. Surgeon focused. Patient driven. TM

Fracture fixation. Types. Mechanical considerations. Biomechanics of fracture fixation. External fixation. Internal fixation

BRIDGE PLATING OF COMMINUTED SHAFT OF FEMUR FRACTURES

Zimmer Segmental System

DEMINERALIZED BONE MATRIX

Gene Activation for Excellent Bone Remodeling

Arcos Modular Femoral Revision System

EVOS MINI with IM Nailing

Norian Drillable: A Competitive Analysis

Tibial Nailing for Tibial Shaft Fracture

Osteosynthesis involving a joint Thomas P Rüedi

PRO-DENSE BONE GRAFT SUBSTITUTE

OSS Modular Arthrodesis System. Assembly Guide

SPINE BIOMATERIALS Crop Bleed

Graftys Quickset & Graftys HBS use in plateau tibial fracture

synthetic CANCELLOUS BONE technical monograph Presented by Barbara Blum, Ph.D.

Technique Manual Technique Manual Rev. A 01/11/2011

End-To-End Solution Posterior Lumbar. A comprehensive offering of complementary products.

The Essential Choice. With the Benefits of Biologic Predictability

PRO-DENSE Bone Graft Substitute The following languages are included in this packet:

Fractures of the Hand in Children Which are simple? And Which have pitfalls??

PRO-STIM Injectable Inductive Graft TECHNICAL MONOGRAPH

CASE REPORT. Bone transport utilizing the PRECICE Intramedullary Nail for an infected nonunion in the distal femur

Regenerex Porous Titanium Construct. Knees Hips Extremities Cement and Accessories PMI Trauma Technology

DISTAL RADIUS. Instructions for Use

A Clinical Study For Evaluation Of Results Of Closed Interlocking Nailing Of Fractures Of The Shaft Of The Tibia

Knee spanning solutions

Tibial plateau fractures are common injuries that result from

DermaSpan Acellular Dermal Matrix. Reinforcement of Ruptured Posterior Tibial Tendon Repair. Surgical Protocol by Charles Zelen, DPM, FACFAS

Bone Tissue Biology & The Application of Synthetic Compounds for the Facilitation of Bone Tissue Healing

The Essential Choice. With the Benefits of Biologic Predictability

Tibial Plateau Fractures: Factors influencing outcomes

Bone healing, delayed fracture healing and nonunion. Norbert Wiegand

Ankle and subtalar arthrodesis

Surgical Care at the District Hospital. EMERGENCY & ESSENTIAL SURGICAL CARE

NeuroMend. Collagen Wrap Conduits. Operative Technique

BRAINLAB ORTHOPEDICS SOFTWARE SOLUTIONS TO IMPROVE PATIENT CARE

Transcription:

POWER TO RESTORE WITHOUT LEAVING A TRACE The only remaining evidence of the trauma

Perfect partner for your trauma and non-unions Your choice of synthetic bone graft not only influences the efficiency of each surgical procedure, it has considerable impact on the long-term outcome. genex is a catalyst for bone healing. It complements the body s natural healing processes and encourages normal bone structure to be restored at a steady rate. Over 12 months, the graft matrix is completely absorbed and replaced by bone. 1,2 No foreign artifacts are left behind to impair structural integrity. Cleared for bony voids and defects that are not intrinsic to the stability of the bony structure An innovative, versatile choice that supports natural healing, then vanishes without a trace

genex offers successful long-term outcomes across a range of surgical applications, including tibial plateau fractures and long-bone non-unions TIBIAL PLATEAU FRACTURE 3 * Patient presented with: Comminuted Schatzker type II fracture of right leg. X-ray examination revealed 2 large fragments and several small fragments. Outcome: At 15 months follow-up the fracture had healed and knee was stable, with a range of motion of 0 130. genex had completely absorbed. PROXIMAL FEMUR FRACTURE 2 * Patient presented with: Failed intramedullary nailing of an extracapsular neck of femur fracture. Patient complained of prominent metalwork and pain. Outcome: At 12 months follow-up the fracture had healed with complete absorption of genex. Patient had a good range of hip motion and was able to walk and manage stairs. DISTAL TIBIA NON-UNION 4 * Patient presented with: Healed fibula with a non-union of the distal tibia and a fracture through the nail, 19 months after the initial operation. Outcome: At 10 months follow-up the non-union had healed completely, patient had fully recovered and was scheduled to have the intramedullary nail removed. *Additional information and case studies available on request.

Designed to be completely absorbed and leave no trace genex is a precisely balanced ß-tricalcium phosphate/calcium sulfate hemihydrate compound with distinct design properties: Contains no hydroxyapatite (HA) Negatively charged surface chemistry genex provides a powerful scaffold for accelerated bone restoration and helps to hinder soft tissue ingrowth: Fully absorbed within 12 months Enhances osteogenic response Restores strong healthy bone Completely absorbed within 12 months 1,2 genex contains no hydroxyapatite. HA can only be absorbed at 1 2% per year 5 genex implantation 1 8 weeks 16 weeks 36 weeks Large animal model. Decalcified histology H & E stain.

Enhances the osteogenic response to accelerate bone growth 5x normal levels 6 35 30 +136% CONCENTRATION (µg/ml) 25 20 15 10 5 +486% +516% +93% +160% +11% +38% +34% DAY 3 DAY 21 DAY 3 DAY 21 DAY 3 DAY 21 DAY 3 DAY 21 CBFA1 OSTEOCALCIN OSTEONECTIN OSTEOPONTIN Negatively charged surface chemistry Positively charged surface chemistry Restores strong healthy bone within a clinically relevant timeframe 2,3 Tibial plateau fracture Post-operative 15 months genex restores bone to normal trabecular structure in 36 weeks 1

Versatility at your fingertips genex is versatile and easy to prepare. It comes as a paste or putty in a range of volumes. The paste sets within 15 minutes at body temperature, and can be digitally implanted or injected in difficult-to-reach sites or minimally invasive procedures. genex genex ds genex putty A range of surgical applications PRODUCT PASTE VOLUME SETTING TIMES ORDER CODES genex Setting paste for molding, injecting and packing 5cc 10cc 15 minutes approx. 900-005 900-010 genex ds Setting paste for difficult-to-reach surgical sites 2.5cc 5cc 15 minutes approx. 980-002 980-005 2.5cc 920-002 genex putty Non-setting putty that requires no mixing 5cc Non-setting 920-005 10cc 920-010

POWER TO RESTORE WITHOUT LEAVING A TRACE Perfect partner for your trauma and non-unions Designed to be completely absorbed and leave no trace 1,2 Versatility at your fingertips At Biocomposites, we are proud to be driving improved outcomes across a wide range of clinical applications for patients and surgeons. Our team of specialists is singularly focused on the development of innovative calcium compounds for surgical use. With over 30 years experience and an unrivaled dedication to quality, the products we research, engineer and manufacture are at the forefront of calcium technology. All Biocomposites products are engineered, manufactured and shipped from our facilities in Keele, UK. References: 1.Yang HL et al. Bone healing response to a synthetic calcium sulfate/beta-tricalcium phosphate graft material in a sheep vertebral body defect model. J Biomed Mater Res B Appl Biomater 2012;100B(7):1911 21. 2. Data on file, Mr A Nissar and Mr S Gopal. 3. Data on file, Mr HK Sharma. 4. Data on file, Prof JB Richardson. 5. Pina S, Ferreira JMF. Bioresorbable plates and screws for clinical applications: A review. J Healthcare Engineering 2012;3(2):243 60. 6. Cooper JJ et al. Enhancing the osteogenic potential of bioabsorbable implants through control of surface charge. Presented at the Society for Biomaterials 2007 Annual Meeting, April, 2007: Chicago, Illinois, USA. For indications, contraindications, warnings and precautions see Instructions for Use. 2018, Biocomposites, genex and Power to Restore are trademarks/registered trademarks of Biocomposites Ltd. All rights reserved. No unauthorized copying, reproduction, distributing or re-publication is allowed unless prior written permission is granted by the owner, Biocomposites Ltd. Patents granted: EP 1390086 B1, US 8632796, CN ZL02809194.9, US 8496955 MA0118R2